TERT and metastatic malignant neoplasm in the lymph nodes: In another study reported by Vuong et al., the rate of TERT promoter mutation with BRAFV600E mutation was 5.8% and has been associated with aggressive behaviors of cancer, such as advanced T stage and overall stage, extrathyroidal extension, lymph node metastasis, distant metastasis and increased recurrence [22].